
Surgalign Holdings SRGA
Quarterly report 2023-Q1
added 05-11-2023
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
6.56 M |
Market Cap[1] |
$ 1.68 M |
EBITDA (LTM) |
$ -27.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.02 |
EPS (LTM) |
-3.52 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
- | - | $ 1.05 B | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.6 | 4.2 % | $ 135 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.22 | 2.78 % | $ 1.35 M | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.47 | 3.33 % | $ 325 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.12 | 0.47 % | $ 402 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.57 | -5.8 % | $ 35.5 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 66.26 | 15.05 % | $ 3.61 B | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 11.26 | -2.34 % | $ 403 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.04 | -0.95 % | $ 17.6 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Electromed
ELMD
|
- | 0.5 % | $ 219 M | NYSE American | ||
|
Myomo
MYO
|
$ 0.85 | -2.78 % | $ 35.6 M | NYSE American | ||
|
Butterfly Network
BFLY
|
$ 4.55 | -5.6 % | $ 963 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 12.19 | -2.01 % | $ 483 M | Nasdaq Global Select Market,SPB | ||
|
Insulet Corporation
PODD
|
- | - | $ 10.6 B | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 89.22 | -0.9 % | $ 12.1 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.4 | -0.83 % | $ 6.66 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 37.32 | 1.86 % | $ 1.16 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 45.7 | -5.42 % | $ 1.34 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 86.29 | 0.51 % | $ 3 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Stryker Corporation
SYK
|
$ 292.33 | -0.99 % | $ 112 B | NYSE,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 83.2 | 0.35 % | $ 48.7 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
- | - | $ 2.48 B | Nasdaq Global Market | ||
|
Tactile Systems Technology
TCMD
|
$ 25.3 | 5.2 % | $ 579 M | Nasdaq Global Select Market,SPB | ||
|
Tandem Diabetes Care
TNDM
|
- | - | $ 1.23 B | Nasdaq Global Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.39 | -1.73 % | $ 64.5 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.